Application 215677
- Type
- ANDA
- Sponsor
- ALEMBIC PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RIBOCICLIB | RIBOCICLIB | TABLET; ORAL | 200MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KISQALI | RIBOCICLIB | Novartis Pharmaceuticals Corporation | aaeaef94-f3f5-4367-8ea2-b181d7be2da8 | 2026-07-01 | Warnings, Adverse reactions | RIBOCICLIB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.